APA (7th ed.) Citation

Lv, B., Gao, X., Zeng, G., Guo, H., & Li, F. (2024). Safety Profile of Paxlovid in the Treatment of COVID-19. Current pharmaceutical design, 30(9), 666. https://doi.org/10.2174/0113816128280987240214103432

Chicago Style (17th ed.) Citation

Lv, Bing, Xin Gao, Guoqiang Zeng, Hui Guo, and Faping Li. "Safety Profile of Paxlovid in the Treatment of COVID-19." Current Pharmaceutical Design 30, no. 9 (2024): 666. https://doi.org/10.2174/0113816128280987240214103432.

MLA (9th ed.) Citation

Lv, Bing, et al. "Safety Profile of Paxlovid in the Treatment of COVID-19." Current Pharmaceutical Design, vol. 30, no. 9, 2024, p. 666, https://doi.org/10.2174/0113816128280987240214103432.